European Radiology:甲状舌管囊肿该如何进行术式选择?乙醇消融治疗看一看

2022-04-07 shaosai MedSci原创

手术(即Sistrunk手术)被认为是治疗甲状舌管囊肿的标准方法,其最重要的优点是术后复发率低,而Sistrunk手术切除范围更广,包括部分舌头以及舌骨中央部分的三分之一。

甲状舌管囊肿(TGDC)是最常见的先天性颈部肿块,因为外观问题和复发性感染需要进行治疗。手术(即Sistrunk手术)被认为是治疗TGDCs的标准方法,其最重要的优点是术后复发率低。然而,Sistrunk手术切除范围更广,包括部分舌头以及舌骨中央部分的三分之一。因此,术后并发症的风险相对较高,同时存在与全身麻醉和手术发病率相关的潜在风险。因此,微创治疗如乙醇消融(EA)技术已引入临床

根据以往的研究,EA治疗TGDC的成功率很高,在最后的随访检查中,平均体积缩小率(VRR)为75-82%。使用EA也可以改善症状和外观情况,而且没有出现严重的并发症。然而尽管EA被证明是治疗TGDC的一种有效和安全的术式选择,但以前的研究涉及的随访期相当短,大多数单中心研究因此参考价值有限

近日,发表在European Radiology杂志的一项研究评估了EA治疗TGDC的2年疗效和安全性,为患者选择EA治疗TGDC提供了信心

项回顾性研究包括2008年1月至2018年10月期间在两个机构诊断和治疗的81名连续患者,每位患者都是有症状的TGDCs患者。术前评估包括US评估以及计算TGDC体积。在US指导下使用99%的乙醇进行EA治疗。治疗后的随访安排在3个月、6个月,然后每年一次。即时成功被定义为3个月内体积缩小率(VRR;EA后的体积差与初始TGDC体积之比)>50%。长期成功的定义是VRR>50%或在最后一次随访时外观问题和症状得到解决或改善而没有复发。 

77名患者接受了EA治疗,并对68名有随访数据的患者进行了结果评估。第一次EA的即时成功率为81%(55/68),3个月内平均VRR为73%±31%。一名患者(1.5%,1/68)在第一次EA后出现伤口炎症。42名患者的随访时间超过了2年。随访的中位数为69个月(范围为24-131个月),长期成功率为83%(35/42),最后一次随访的平均VRR为81% ± 35%。没有患者因消融的TGDCs而发生恶变。 

 一个13岁的女性患者,在第一次EA后63个月TGDC复发。a横向超声(US)显示在中线下颈部有一个薄壁无回声病变,提示是TGDC(体积,1.6毫升)。c 第一次EA后3个月的US显示TGDC的体积缩小(0.4 mL;体积缩小率(VRR),75%)。d 在第一次EA后63个月,为评估治疗部位可触及的病变复发而进行的US显示,治疗后的TGDC体积增大(2.3 mL),表明复发

总之,EA治疗TGDCs取得了临床可接受的近期和长期疗效,并发症发生率低,因此可以考虑作为治疗TGDCs的一线疗法在临床广泛应用

原文出处:

Sang Ik Park,Jung Hwan Baek,Sae Rom Chung,et al.Ethanol ablation for the treatment of thyroglossal duct cysts: follow-up results for longer than 2 years.DOI:10.1007/s00330-021-08402-x

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2028090, encodeId=d26e202809020, content=<a href='/topic/show?id=1ebf234842a' target=_blank style='color:#2F92EE;'>#乙醇消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23484, encryptionId=1ebf234842a, topicName=乙醇消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Tue Jun 14 08:45:17 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729478, encodeId=94fd1e29478ab, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Nov 15 20:45:17 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223254, encodeId=27b212232543a, content=确实带来了新思路!证实我想要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKWiaYLDmIu2ROHOhE1SwoXzHCWQGBRiaAkGSsBObcIxHenuchuX0foxhibmtiaKhSyDq6YicYGxSEOuiaw/132, createdBy=7fe092899, createdName=rainbow2009, createdTime=Sun May 29 23:06:18 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209502, encodeId=3ae5120950258, content=简单的治疗病例经过好的研究设计和好的临床问题的提出,也是有机会在高分杂志发表的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28426587574, createdName=ms3000000628159297, createdTime=Fri Apr 08 10:15:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340866, encodeId=dc0613408669c, content=<a href='/topic/show?id=74a140404de' target=_blank style='color:#2F92EE;'>#囊肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40404, encryptionId=74a140404de, topicName=囊肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32a12500167, createdName=12498ca5m83暂无昵称, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421895, encodeId=998c1421895ad, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597775, encodeId=7d37159e775e5, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2028090, encodeId=d26e202809020, content=<a href='/topic/show?id=1ebf234842a' target=_blank style='color:#2F92EE;'>#乙醇消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23484, encryptionId=1ebf234842a, topicName=乙醇消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Tue Jun 14 08:45:17 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729478, encodeId=94fd1e29478ab, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Nov 15 20:45:17 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223254, encodeId=27b212232543a, content=确实带来了新思路!证实我想要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKWiaYLDmIu2ROHOhE1SwoXzHCWQGBRiaAkGSsBObcIxHenuchuX0foxhibmtiaKhSyDq6YicYGxSEOuiaw/132, createdBy=7fe092899, createdName=rainbow2009, createdTime=Sun May 29 23:06:18 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209502, encodeId=3ae5120950258, content=简单的治疗病例经过好的研究设计和好的临床问题的提出,也是有机会在高分杂志发表的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28426587574, createdName=ms3000000628159297, createdTime=Fri Apr 08 10:15:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340866, encodeId=dc0613408669c, content=<a href='/topic/show?id=74a140404de' target=_blank style='color:#2F92EE;'>#囊肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40404, encryptionId=74a140404de, topicName=囊肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32a12500167, createdName=12498ca5m83暂无昵称, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421895, encodeId=998c1421895ad, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597775, encodeId=7d37159e775e5, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-11-15 feather89
  3. [GetPortalCommentsPageByObjectIdResponse(id=2028090, encodeId=d26e202809020, content=<a href='/topic/show?id=1ebf234842a' target=_blank style='color:#2F92EE;'>#乙醇消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23484, encryptionId=1ebf234842a, topicName=乙醇消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Tue Jun 14 08:45:17 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729478, encodeId=94fd1e29478ab, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Nov 15 20:45:17 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223254, encodeId=27b212232543a, content=确实带来了新思路!证实我想要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKWiaYLDmIu2ROHOhE1SwoXzHCWQGBRiaAkGSsBObcIxHenuchuX0foxhibmtiaKhSyDq6YicYGxSEOuiaw/132, createdBy=7fe092899, createdName=rainbow2009, createdTime=Sun May 29 23:06:18 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209502, encodeId=3ae5120950258, content=简单的治疗病例经过好的研究设计和好的临床问题的提出,也是有机会在高分杂志发表的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28426587574, createdName=ms3000000628159297, createdTime=Fri Apr 08 10:15:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340866, encodeId=dc0613408669c, content=<a href='/topic/show?id=74a140404de' target=_blank style='color:#2F92EE;'>#囊肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40404, encryptionId=74a140404de, topicName=囊肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32a12500167, createdName=12498ca5m83暂无昵称, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421895, encodeId=998c1421895ad, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597775, encodeId=7d37159e775e5, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-05-29 rainbow2009

    确实带来了新思路!证实我想要的!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2028090, encodeId=d26e202809020, content=<a href='/topic/show?id=1ebf234842a' target=_blank style='color:#2F92EE;'>#乙醇消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23484, encryptionId=1ebf234842a, topicName=乙醇消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Tue Jun 14 08:45:17 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729478, encodeId=94fd1e29478ab, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Nov 15 20:45:17 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223254, encodeId=27b212232543a, content=确实带来了新思路!证实我想要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKWiaYLDmIu2ROHOhE1SwoXzHCWQGBRiaAkGSsBObcIxHenuchuX0foxhibmtiaKhSyDq6YicYGxSEOuiaw/132, createdBy=7fe092899, createdName=rainbow2009, createdTime=Sun May 29 23:06:18 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209502, encodeId=3ae5120950258, content=简单的治疗病例经过好的研究设计和好的临床问题的提出,也是有机会在高分杂志发表的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28426587574, createdName=ms3000000628159297, createdTime=Fri Apr 08 10:15:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340866, encodeId=dc0613408669c, content=<a href='/topic/show?id=74a140404de' target=_blank style='color:#2F92EE;'>#囊肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40404, encryptionId=74a140404de, topicName=囊肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32a12500167, createdName=12498ca5m83暂无昵称, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421895, encodeId=998c1421895ad, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597775, encodeId=7d37159e775e5, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
    2022-04-08 ms3000000628159297

    简单的治疗病例经过好的研究设计和好的临床问题的提出,也是有机会在高分杂志发表的!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2028090, encodeId=d26e202809020, content=<a href='/topic/show?id=1ebf234842a' target=_blank style='color:#2F92EE;'>#乙醇消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23484, encryptionId=1ebf234842a, topicName=乙醇消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Tue Jun 14 08:45:17 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729478, encodeId=94fd1e29478ab, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Nov 15 20:45:17 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223254, encodeId=27b212232543a, content=确实带来了新思路!证实我想要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKWiaYLDmIu2ROHOhE1SwoXzHCWQGBRiaAkGSsBObcIxHenuchuX0foxhibmtiaKhSyDq6YicYGxSEOuiaw/132, createdBy=7fe092899, createdName=rainbow2009, createdTime=Sun May 29 23:06:18 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209502, encodeId=3ae5120950258, content=简单的治疗病例经过好的研究设计和好的临床问题的提出,也是有机会在高分杂志发表的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28426587574, createdName=ms3000000628159297, createdTime=Fri Apr 08 10:15:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340866, encodeId=dc0613408669c, content=<a href='/topic/show?id=74a140404de' target=_blank style='color:#2F92EE;'>#囊肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40404, encryptionId=74a140404de, topicName=囊肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32a12500167, createdName=12498ca5m83暂无昵称, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421895, encodeId=998c1421895ad, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597775, encodeId=7d37159e775e5, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2028090, encodeId=d26e202809020, content=<a href='/topic/show?id=1ebf234842a' target=_blank style='color:#2F92EE;'>#乙醇消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23484, encryptionId=1ebf234842a, topicName=乙醇消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Tue Jun 14 08:45:17 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729478, encodeId=94fd1e29478ab, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Nov 15 20:45:17 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223254, encodeId=27b212232543a, content=确实带来了新思路!证实我想要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKWiaYLDmIu2ROHOhE1SwoXzHCWQGBRiaAkGSsBObcIxHenuchuX0foxhibmtiaKhSyDq6YicYGxSEOuiaw/132, createdBy=7fe092899, createdName=rainbow2009, createdTime=Sun May 29 23:06:18 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209502, encodeId=3ae5120950258, content=简单的治疗病例经过好的研究设计和好的临床问题的提出,也是有机会在高分杂志发表的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28426587574, createdName=ms3000000628159297, createdTime=Fri Apr 08 10:15:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340866, encodeId=dc0613408669c, content=<a href='/topic/show?id=74a140404de' target=_blank style='color:#2F92EE;'>#囊肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40404, encryptionId=74a140404de, topicName=囊肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32a12500167, createdName=12498ca5m83暂无昵称, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421895, encodeId=998c1421895ad, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597775, encodeId=7d37159e775e5, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2028090, encodeId=d26e202809020, content=<a href='/topic/show?id=1ebf234842a' target=_blank style='color:#2F92EE;'>#乙醇消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23484, encryptionId=1ebf234842a, topicName=乙醇消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2f5a410, createdName=zxxiang, createdTime=Tue Jun 14 08:45:17 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1729478, encodeId=94fd1e29478ab, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Nov 15 20:45:17 CST 2022, time=2022-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223254, encodeId=27b212232543a, content=确实带来了新思路!证实我想要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKWiaYLDmIu2ROHOhE1SwoXzHCWQGBRiaAkGSsBObcIxHenuchuX0foxhibmtiaKhSyDq6YicYGxSEOuiaw/132, createdBy=7fe092899, createdName=rainbow2009, createdTime=Sun May 29 23:06:18 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209502, encodeId=3ae5120950258, content=简单的治疗病例经过好的研究设计和好的临床问题的提出,也是有机会在高分杂志发表的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28426587574, createdName=ms3000000628159297, createdTime=Fri Apr 08 10:15:50 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1340866, encodeId=dc0613408669c, content=<a href='/topic/show?id=74a140404de' target=_blank style='color:#2F92EE;'>#囊肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40404, encryptionId=74a140404de, topicName=囊肿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32a12500167, createdName=12498ca5m83暂无昵称, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1421895, encodeId=998c1421895ad, content=<a href='/topic/show?id=4bc865819d2' target=_blank style='color:#2F92EE;'>#消融#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65819, encryptionId=4bc865819d2, topicName=消融)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a193676008, createdName=xiangyuzhou972, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597775, encodeId=7d37159e775e5, content=<a href='/topic/show?id=28986582e02' target=_blank style='color:#2F92EE;'>#消融治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65827, encryptionId=28986582e02, topicName=消融治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f07818523366, createdName=zhishijing, createdTime=Thu Apr 07 06:45:17 CST 2022, time=2022-04-07, status=1, ipAttribution=)]

相关资讯

2018 KSThR共识声明:甲状腺结节乙醇消融治疗

有症状的甲状腺结节微创治疗很常见,乙醇消融治疗甲状腺囊性结节于20世纪90年代起开始实施,但是还没有全球性的共识和治疗。本文主要针对甲状腺结节乙醇消融治疗的相关内容提出指导建议。